# A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects

> **NCT02934269** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** CC-90006

## Key facts

- **NCT ID:** NCT02934269
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-21
- **Primary completion:** 2017-08-15
- **Final completion:** 2017-08-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934269, "A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT02934269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*